Abstract: Chemical compounds of formula (I):
and pharmaceutically acceptable salts and addition compounds and prodrugs thereof are useful in therapy, particularly for the treatment of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes inspidus, and sleep apnea.
Type:
Grant
Filed:
October 9, 2001
Date of Patent:
October 5, 2004
Assignee:
Vernalis Research Limited
Inventors:
David Reginald Adams, Jon Mark Bentley, James Davidson, Matthew Alexander James Duncton, Richard Hugh Phillip Porter